<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Moro RN</submitter><funding>Northrop Grumman</funding><funding>Intramural CDC HHS</funding><pagination>526-535</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11380802</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>58(4)</volume><pubmed_abstract>&lt;h4>Introduction&lt;/h4>Characterization of emergency department visits attributed to adverse events involving benzodiazepines can be used to guide preventive interventions. This study describes U.S. emergency department visits attributed to adverse events involving benzodiazepines by intent, patient characteristics, and clinical manifestations.&lt;h4>Methods&lt;/h4>Data from the 2016-2017 National Electronic Injury Surveillance System-Cooperative Adverse Drug Event Surveillance project were analyzed in 2019 to calculate estimated annual numbers and rates of emergency department visits attributed to adverse events involving benzodiazepines, by intent of benzodiazepine use.&lt;h4>Results&lt;/h4>Based on 6,148 cases, there were an estimated 212,770 (95% CI=167,163, 258,377) emergency department visits annu</pubmed_abstract><journal>American journal of preventive medicine</journal><pubmed_title>Emergency Department Visits Attributed to Adverse Events Involving Benzodiazepines, 2016-2017.</pubmed_title><pmcid>PMC11380802</pmcid><funding_grant_id>CC999999</funding_grant_id><pubmed_authors>Weidle NJ</pubmed_authors><pubmed_authors>Lovegrove MC</pubmed_authors><pubmed_authors>Lind JN</pubmed_authors><pubmed_authors>Dowell D</pubmed_authors><pubmed_authors>Geller AI</pubmed_authors><pubmed_authors>McAninch JK</pubmed_authors><pubmed_authors>Goring SK</pubmed_authors><pubmed_authors>Budnitz DS</pubmed_authors><pubmed_authors>Moro RN</pubmed_authors><pubmed_authors>Rose KO</pubmed_authors></additional><is_claimable>false</is_claimable><name>Emergency Department Visits Attributed to Adverse Events Involving Benzodiazepines, 2016-2017.</name><description>&lt;h4>Introduction&lt;/h4>Characterization of emergency department visits attributed to adverse events involving benzodiazepines can be used to guide preventive interventions. This study describes U.S. emergency department visits attributed to adverse events involving benzodiazepines by intent, patient characteristics, and clinical manifestations.&lt;h4>Methods&lt;/h4>Data from the 2016-2017 National Electronic Injury Surveillance System-Cooperative Adverse Drug Event Surveillance project were analyzed in 2019 to calculate estimated annual numbers and rates of emergency department visits attributed to adverse events involving benzodiazepines, by intent of benzodiazepine use.&lt;h4>Results&lt;/h4>Based on 6,148 cases, there were an estimated 212,770 (95% CI=167,163, 258,377) emergency department visits annu</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Apr</publication><modification>2026-05-29T07:07:35.325Z</modification><creation>2025-04-05T14:38:41.882Z</creation></dates><accession>S-EPMC11380802</accession><cross_references><pubmed>32089287</pubmed><doi>10.1016/j.amepre.2019.11.017</doi></cross_references></HashMap>